January 5 Drugs & Diseases On the Shelf Evening primrose oil PT January 2023 Best known for treating inflammation, evening primrose oil (EPO) has been a popular supplement for centuries used to address a host of conditions. Mickie Cathers
January 5 Drugs & Diseases Antidepressants & Depression USPSTF recommends anxiety screening for youth PT January 2023 The US Preventive Services Task Force (USPSTF) now recommends that children and adolescents should be screened for anxiety. Johanna Taylor Katroscik, PharmD
January 5 Drugs & Diseases Antidepressants Antidepressant use in pregnancy comes more into focus PT January 2023 Studying antidepressant use in pregnancy has led to an abundance of research, but without many answers. Loren Bonner
January 5 Drugs & Diseases Meds and Food What medications can be taken with and without food? PT January 2023 Many medications can be taken without regard to meals, but which ones need to be taken with food? Lauren Howell, PharmD
January 5 Drugs & Diseases New Drug Patients with heart failure have a new treatment option PT January 2023 After rejecting approval twice, FDA has approved Furoscix (ScPharmaceuticals). Lauren Howell, PharmD
January 5 Practice & Trends Payment Out-of-pocket expenses for COVID-19 tests, treatments, and vaccines on horizon for patients PT January 2023 Once the COVID-19 public health emergency (PHE) is lifted, COVID-19 tests, treatments, and vaccines will no longer be “free” for all. Clarissa Chan, PharmD
January 5 Practice & Trends Drug Pricing Rationing common among insulin users, study finds PT January 2023 Insulin rationing is common among adults with type 1 or type 2 diabetes. Sonya Collins
January 5 Practice & Trends Self-Care Pharmacists' Picks of the Top Self-Care Products PT January 2023 Pharmacy Today proudly presents APhA’s Self-Care Product Survey.
January 5 Practice & Trends On the Docket Court rules that pharmacy information sheets fulfill duty to warn PT January 2023 A Connecticut court recently issued a ruling that places an otherwise “ordinary” pharmacist duty to warn case into the category of “interesting.” David B. Brushwood, BSPharm, JD
January 5 Health Systems Inpatient Insights PT January 2023 Extended rivaroxaban treatment could reduce risk of recurrent venous thromboembolism.